Transgenic PD mice (4 mo old) were treated with EV-GDNF (3 × 109 particles/10 μL/mouse) once a week, 3 times, and their locomotor functions were assessed in a battery of behavioral tests (Figure 3). This evidence concerns the gene GDNF and Parkinson disease.